Patent injunctions vs. software encroachment

Epstein contrasts pharma's need for injunctions with software's complex patent-assembly problems.

Play episode from 16:22

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!